Medical device stocks

The best medical device stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.

How to buy medical device stocks

Sign up with an online broker or platform to invest in one of more of these medical device stocks.

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Use our comparison table to narrow down top brokers by fees and bonuses.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for the stock you're interested in. Find the stock by name or ticker symbol, like ABT or ABMD. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Invest in the health product industry today with a market order or use a limit order to delay your purchase until the stock reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy fractional shares, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of a medical device company. Optimize your portfolio by tracking how your stock — and even the health product sector as a whole — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Compare medical device stocks

We round up a selection of stocks in or related to the health product industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

---

1. Abbott Laboratories (ABT)

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Abbott Laboratories stock opened the day at $123.82 after a previous close of $124.40. The latest price was $125.10 (25 minute delay). Abbott Laboratories is listed on the NYSE, has a trailing 12-month revenue of around USD34.6 billion and employs 109,000 staff.

• Market capitalization: $215,240,900,608
• P/E ratio: 48.5417
• PEG ratio: 3.0561

---

2. Abiomed (ABMD)

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients.

Abiomed stock opened the day at $328.01 after a previous close of $330.53. The latest price was $329.04 (25 minute delay). Abiomed is listed on the NASDAQ, has a trailing 12-month revenue of around USD$812.9 million and employs 1,536 staff.

• Market capitalization: $15,083,634,688
• P/E ratio: 76.0155
• PEG ratio: 2.75

---

3. Align Technology (ALGN)

Align Technology, Inc. , a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.

Align Technology stock opened the day at $608.31 after a previous close of $606.33. The latest price was $594.93 (25 minute delay). Align Technology is listed on the NASDAQ, has a trailing 12-month revenue of around USD$2.5 billion and employs 18,070 staff.

• Market capitalization: $47,080,140,800
• P/E ratio: 26.5475
• PEG ratio: 3.7789

---

4. Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery.

Edwards Lifesciences Corporation stock opened the day at $88.38 after a previous close of $89.08. The latest price was $88.73 (25 minute delay). Edwards Lifesciences Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$4.4 billion and employs 14,900 staff.

• Market capitalization: $54,739,165,184
• P/E ratio: 67.6923
• PEG ratio: 2.3257

---

5. Boston Scientific Corporation (BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems.

Boston Scientific Corporation stock opened the day at $40.73 after a previous close of $40.91. The latest price was $40.81 (25 minute delay). Boston Scientific Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$9.9 billion and employs 38,000 staff.

• Market capitalization: $56,352,022,528
• P/E ratio: 15.1017
• PEG ratio: 2.0311

---

6. Medtronic (MDT)

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software.

Medtronic stock opened the day at $125.32 after a previous close of $125.99. The latest price was $125.78 (25 minute delay). Medtronic is listed on the NYSE, has a trailing 12-month revenue of around USD$27.9 billion and employs 90,000 staff.

• Market capitalization: $167,025,885,184
• P/E ratio: 54.8473
• PEG ratio: 2.8218

---

7. Penumbra (PEN)

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands.

Penumbra stock opened the day at $264.89 after a previous close of $264.90. The latest price was $262.63 (25 minute delay). Penumbra is listed on the NYSE, has a trailing 12-month revenue of around USD$560.4 million and employs 3,300 staff.

• Market capitalization: $10,436,720,640
• P/E ratio: 813.7931
• PEG ratio: -62.27

---

8. Inogen (INGN)

Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Inogen stock opened the day at $47.94 after a previous close of $47.44. The latest price was $46.89 (25 minute delay). Inogen is listed on the NASDAQ, has a trailing 12-month revenue of around USD$308.5 million and employs 938 staff.

• Market capitalization: $1,461,249,664
• P/E ratio: 98.7586
• PEG ratio: 3.48

---

9. SmileDirectClub (SDC)

SmileDirectClub, Inc. operates as an oral care company. It offers clear aligner therapy treatment.

SmileDirectClub stock opened the day at $10.63 after a previous close of $10.52. The latest price was $10.37 (25 minute delay). SmileDirectClub is listed on the NASDAQ, has a trailing 12-month revenue of around USD$607.4 million and employs 4,000 staff.

• Market capitalization: $3,923,592,192

Compare trading platforms

Compare online trading platforms by fees, asset types and bonuses to find the best for your investment in medical device stocks.

*Signup bonus information updated weekly.

Bottom line

While it’s possible to turn a profit investing in medical device stocks, keep in mind that — like any investment — medical device stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the health product industry, so carefully vet your picks before you invest. And if you’re new to investing, or if it’s been awhile since you’ve taken a critical look at your investing accounts, compare brokers to make sure you’re getting the best features in your trading account.